AIG
PRAX icon

American International Group’s Praxis Precision Medicines PRAX Stock Holding History

American International Group’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,535
Closed -$18.6K – 3148
2023
Q1 		$18.6K Buy
1,535
+300
+24% +$12.7K ﹤0.01% 2901
2022
Q4 		$44.1K Buy
1,235
+38
+3% +$1.19K ﹤0.01% 2781
2022
Q3 		$41K Buy
1,197
+17
+1% +$847 ﹤0.01% 2861
2022
Q2 		$43K Buy
1,180
+77
+7% +$8.22K ﹤0.01% 2911
2022
Q1 		$169K Sell
1,103
-77
-7% -$15.8K ﹤0.01% 2344
2021
Q4 		$349K Sell
1,180
-2
-0.2% -$587 ﹤0.01% 2036
2021
Q3 		$328K Buy
1,182
+271
+30% +$73.5K ﹤0.01% 2124
2021
Q2 		$250 Buy
911
+482
+112% +$173K ﹤0.01% 2362
2021
Q1 		$211 Buy
429
+2
+0.5% +$1.42K ﹤0.01% 2337
2020
Q4 		$353 Buy
+427
New +$249K ﹤0.01% 1948

Other funds holding PRAX

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
TLP
Tri Locum Partners New York $713M AUM 68.92% 1-Year Est. Return

American International Group's PRAX Position: Q2 2023 in Review

American International Group sold out of Praxis Precision Medicines (PRAX) in Q2 2023, closing a stake of 1,535 shares — an estimated $18.6K sold.

American International Group first reported a position in PRAX in Q4 2020 and held it in 10 quarters. The position peaked at $349K in Q4 2021. 78 funds tracked by Wall St. Rank hold PRAX as of Q2 2023.

  • American International Group reported no remaining Praxis Precision Medicines position as of Q2 2023 after selling out during the quarter.
  • American International Group sold 1,535 Praxis Precision Medicines shares in Q2 2023, an estimated $18.6K.
  • American International Group first reported a position in Praxis Precision Medicines in Q4 2020 and held it in 10 quarters.
  • American International Group's Praxis Precision Medicines position peaked at $349K in Q4 2021.
  • 78 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2023.

Based on American International Group's 13F filing for Q2 2023, filed 4 Aug 2023.